✦ LIBER ✦

Concern grows over reaction to deaths in clinical trials

✍ Scribed by Macilwain, Colin

Book ID: 109788618
Publisher: Nature Publishing Group
Year: 1994
Tongue: English
Weight: 154 KB
Volume: 369
Category: Article
ISSN: 0028-0836
DOI: 10.1038/369268c0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reactions to mistakes among subjects hig

Reactions to mistakes among subjects high and low in perfectionistic concern over mistakes

✍ Randy O. Frost; Theresa A. Turcotte; Richard G. Heimberg; Jill I. Mattia; Craig 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 472 KB

Inability to obtain deferred consent due

Inability to obtain deferred consent due to early death in emergency research: effect on validity of clinical trial results

✍ Tim C. Jansen; Jan Bakker; Erwin J. O. Kompanje 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 142 KB

Concerns Over Participant Suicides Prema

Concerns Over Participant Suicides Prematurely Abort a Clinical Trial of Potentially Significant Impact on Public Health: How Will We Make Progress in Timid Times?

✍ Joseph F. Cubells 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 60 KB

Advances in data assessment. Application

Advances in data assessment. Application to the etiology of nausea reported during chemotherapy, concerns about significance testing, and opportunities in clinical trials

✍ Gary R. Morrow; Peter M. Black; Deborah J. Dudgeon 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

Typical inferential statistical procedures, such as the t-test and analysis of variance, compare differences in mean values of variables. This approach can sometimes obscure rather than illuminate research data. Here we present and discuss alternative data analytic techniques. Potential advantages o

Changes in the reaction of animals to in

Changes in the reaction of animals to intravenous injection of caffeine and strophanthin after resuscitation from clinical death

✍ Yu. M. Levin 📂 Article 📅 1959 🏛 Springer US 🌐 English ⚖ 501 KB

A call to restructure the drug developme

A call to restructure the drug development process: Government over-regulation and non-innovative late stage (Phase III) clinical trials are major obstacles to advances in health care

✍ Thomas C. Jones 📂 Article 📅 2005 🏛 Springer Netherlands 🌐 English ⚖ 187 KB